We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Researchers from the University of Virginia School of Medicine have discovered that two drugs commonly used to treat asthma, Accolate and Singulair, may be able to offer treatment for those suffering from influenza pneumonia.